MENU
+Compare
CASBF
Stock ticker: OTC
AS OF
Sep 17 closing price
Price
$6.60
Change
+$0.62 (+10.37%)
Capitalization
2.07B

CASBF CANSINO BIOLOGICS INC Forecast, Technical & Fundamental Analysis

CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use... Show more

CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CASBF with price predictions
Sep 29, 2025

Momentum Indicator for CASBF turns positive, indicating new upward trend

CASBF saw its Momentum Indicator move above the 0 level on September 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 55 similar instances where the indicator turned positive. In of the 55 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CASBF just turned positive on September 19, 2025. Looking at past instances where CASBF's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

CASBF broke above its upper Bollinger Band on September 17, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.376) is normal, around the industry mean (17.886). P/E Ratio (0.000) is within average values for comparable stocks, (74.629). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.962). CASBF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (12.723) is also within normal values, averaging (46.048).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CASBF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CASBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
185 South Avenue
Phone
N/A
Employees
2291
Web
https://www.cansinotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIBGX31.80N/A
N/A
Thornburg Investment Income Builder R4
MWOHX63.89N/A
N/A
MFS Global Growth R3
MITEX17.39N/A
N/A
Matthews Asia Innovators Institutional
CENNX13.83N/A
N/A
Centerstone Investors C
CSPYX21.89N/A
N/A
Columbia Small Cap Index Inst3

CASBF and Stocks

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
+32.04%
CNTMF - CASBF
2%
Poorly correlated
+11.70%
BUDZ - CASBF
2%
Poorly correlated
+14.10%
CBWTF - CASBF
1%
Poorly correlated
+3.81%
CPHRF - CASBF
0%
Poorly correlated
N/A
More

Groups containing CASBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
Pharmaceuticals: Generic
industry (223 stocks)
-17%
Poorly correlated
-0.37%